(Q37876599)

24 August 2017

Seropositivity against Chlamydia pneumoniae in patients with coronary atherosclerosis (English)

1 reference

24 August 2017

1 reference

Chlamydia pneumoniae

1 reference

F Romeo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655232&resulttype=core&format=json

15 May 2020

E Martuscelli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655232&resulttype=core&format=json

15 May 2020

G Chirieolo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655232&resulttype=core&format=json

15 May 2020

L M Cerabino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655232&resulttype=core&format=json

15 May 2020

K Ericson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655232&resulttype=core&format=json

15 May 2020

T G Saldeen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655232&resulttype=core&format=json

15 May 2020

J L Mehta

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655232&resulttype=core&format=json

15 May 2020

publication date

1 May 2000

1 reference

24 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655232&resulttype=core&format=json

15 May 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655232&resulttype=core&format=json

15 May 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655232&resulttype=core&format=json

15 May 2020

page(s)

327-330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655232&resulttype=core&format=json

Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model

15 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960230504

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960230504

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960230504

Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960230504

Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960230504

Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960230504

Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960230504

Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile

21 January 2018

1 reference

12 December 2020

Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease

1 reference

12 December 2020

The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae

1 reference

12 December 2020

Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques

1 reference

12 December 2020

Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease

1 reference

12 December 2020

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction

1 reference

12 December 2020

Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis

1 reference

12 December 2020

Growth of Chlamydia psittaci in macrophages

1 reference

12 December 2020

In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae

1 reference

12 December 2020

Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease

1 reference

12 December 2020

Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old)

1 reference

12 December 2020

Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells

1 reference

12 December 2020

Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease

1 reference

12 December 2020

Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications

1 reference

12 December 2020

Murine models of Chlamydia pneumoniae infection and atherosclerosis

1 reference

12 December 2020

Chlamydia species infect human vascular endothelial cells and induce procoagulant activity

1 reference

12 December 2020

Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group

1 reference

12 December 2020

Chlamydia pneumoniae and acute myocardial infarction in Jerusalem

1 reference

12 December 2020

Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease

1 reference

12 December 2020

Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction

1 reference

12 December 2020

Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients.

1 reference

12 December 2020

The National Cholesterol Education Program: progress and prospects

1 reference

12 December 2020

Identifiers

DOI

10.1002/CLC.4960230504

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655232&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655232&resulttype=core&format=json

15 May 2020

1 reference